Perioperative Outcomes During Double-Lung Transplantation and Retransplantation in Cystic Fibrosis Patients: A Monocentric Cohort Study

被引:5
|
作者
Fessler, Julien
Glorion, Matthieu
Finet, Michael
Soniak, Claire
de Verdiere, Sylvie Colin [1 ,2 ]
Sage, Edouard
Roux, Antoine [1 ,2 ]
Zuber, Benjamin [3 ]
Fischler, Marc [5 ]
Le Guen, Morgan
Vallee, Alexandre [4 ]
机构
[1] Univ Versailles St Quentin en Yvelines, Hop Foch, Dept Anesthesiol, Versailles, Yvelines, France
[2] Hop Foch, Dept Thorac Surg & Lung Transplantat, Suresnes, France
[3] Univ Versailles St Quentin en Yvelines, Versailles, Yvelines, France
[4] Hop Foch, Dept Pneumol, Suresnes, France
[5] Hop Foch, Intens Care Unit, Suresnes, France
关键词
cystic fibrosis; lung transplantation; retransplantation; extracorporeal membrane oxygenation; retrospective studies; EXTRACORPOREAL MEMBRANE-OXYGENATION; STATEMENT; SURVIVAL;
D O I
10.1053/j.jvca.2023.02.029
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Objective: Life expectancy for lung-transplant patients, especially those with cystic fibrosis (CF), is leading increasingly to more retransplantations. Design: Retrospective monocentric cohort study. Setting: Foch University Hospital, Suresnes, France. Participants: CF patients having had a primary double-lung transplantation (pLgTx) or a retransplantation (reLgTx) from 2012 to 2021. Interventions: None. Measurements and Main Results: The authors compared the main intraoperative and early postoperative features between pLgTx (n = 258) and reLgTx (n = 24). Demographic characteristics were similar. No patients with retransplantations had a preoperative bridge with extracorporeal membrane oxygenation (ECMO); however, 23 patients had it in the pLgTx group (p = 0.24). Patients with retransplants had longer second graft ischemic time (p = 0.02), larger intraoperative bleeding volume (p = 0.001) and blood transfusion (p = 0.009 for packed red blood cells), increased blood lactate concentrations (p = 0.002), and higher norepinephrine dose at end-surgery (p = 0.001). Extracorporeal membrane oxygen-ation was used during surgery in 94 patients in the pLgTx group and 12 patients in the reLgTx group (p = 0.39). Extracorporeal membrane oxy-genation could not be weaned after surgery in 55 patients in the pLgTx group and 4 in the reLgTx group (p = 0.54). Despite worse preoperative renal function in the reLgTx group (p < 0.001), there was no difference concerning renal replacement therapy in the intensive care unit between groups (p = 0.08). There were no differences between groups concerning the main complications, including primary graft dysfunction. Although the difference was not statistically different (p = 0.17), mortality was 3 times higher in the reLgTx group. Conclusions: Intraoperative period of retransplantation was more convoluted but had a similar ECMO profile to primary transplantation. In addition, the early postoperative period was similar. (c) 2023 Elsevier Inc. All rights reserved.
引用
收藏
页码:964 / 971
页数:8
相关论文
共 50 条
  • [21] Lung transplantation for cystic fibrosis: differential characteristics and outcomes between children and adults
    Moreno, Paula
    Alvarez, Antonio
    Carrasco, Guadalupe
    Redel, Javier
    Dario Guaman, Hugo
    Baamonde, Carlos
    Javier Algar, Francisco
    Cerezo, Francisco
    Salvatierra, Angel
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2016, 49 (05) : 1334 - 1343
  • [22] Cardiopulmonary bypass for lung transplantation in cystic fibrosis: Pilot evaluation of perioperative outcome
    Pochettino, Alberto
    Augoustides, John G. T.
    Kowalchuk, Deborah A.
    Watcha, Sam M.
    Cowie, Doreen
    Jobes, David R.
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2007, 21 (02) : 208 - 211
  • [23] Urgent lung transplantation in cystic fibrosis patients: experience of a French center
    Saueressig, Mauricio Guidi
    Pelluau, Sonia
    Sermet, Isabelle
    Souilamas, Redha
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2011, 40 (03) : E101 - E106
  • [24] Prediction of mortality and timing of referral for lung transplantation in cystic fibrosis patients
    Augarten, A
    Akons, H
    Aviram, M
    Bentur, L
    Blau, H
    Picard, E
    Rivlin, J
    Miller, MS
    Katznelson, D
    Szeinberg, A
    Shmilovich, H
    Paret, G
    Laufer, J
    Yahav, Y
    PEDIATRIC TRANSPLANTATION, 2001, 5 (05) : 339 - 342
  • [25] Lung transplantation in cystic fibrosis patients - Medical followup
    Quattrucci, S
    Cimino, G
    Bertasi, S
    Rendina, E
    Venuta, F
    Vizza, CD
    Della Rocca, G
    Tomaselli, M
    Antonelli, M
    RIVISTA ITALIANA DI PEDIATRIA-ITALIAN JOURNAL OF PEDIATRICS, 1998, 24 (02): : 21 - 23
  • [26] Infections in patients with cystic fibrosis following lung transplantation
    Kanj, SS
    Tapson, V
    Davis, RD
    Madden, J
    Browning, I
    CHEST, 1997, 112 (04) : 924 - 930
  • [27] Lung transplantation in patients with cystic fibrosis: The Israeli experience
    Prais, Dario
    Raviv, Yael
    Shitrit, David
    Yellin, Alon
    Sahar, Gideon
    Bendayan, Danielle
    Yahav, Yaacov
    Efrati, Ori
    Reichart, Nira
    Blau, Hannah
    Bakal, Ilana
    Buchman, Gila
    Saute, Milton
    Vidne, Bernardo
    Kramer, Mordechai R.
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2006, 8 (06): : 396 - 399
  • [28] Perioperative Use of ECMO During Double Lung Transplantation
    Xu, Lingfeng
    Li, Xin
    Xu, Meiyin
    Gao, Chengxin
    Zhu, Jinhong
    Ji, Bingyang
    ASAIO JOURNAL, 2009, 55 (03) : 255 - 258
  • [29] End-stage cystic fibrosis - Improved diabetes control 2 years after successful isolated pancreatic cell and double-lung transplantation
    Tschopp, JM
    Brutsche, MH
    Frey, JG
    Spiliopoulos, A
    Nicod, L
    Rochat, T
    Morel, P
    CHEST, 1997, 112 (06) : 1685 - 1687
  • [30] Risk factors for death of patients with cystic fibrosis awaiting lung transplantation
    Belkin, RA
    Henig, NR
    Singer, LG
    Chaparro, C
    Rubenstein, RC
    Xie, SX
    Yee, JY
    Kotloff, RM
    Lipson, DA
    Bunin, GR
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 173 (06) : 659 - 666